Differential regulation of calmodulin content and calmodulin messenger RNA levels by acute and repeated, intermittent amphetamine in dopaminergic terminal and midbrain areas

Neuroscience

Volumn 98, Issue 2, 2000, Pages 275-285

  Michelhaugh, S K ^a   Gnegy, M E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adaptive responses; Calmodulin genes; Dopamine; Mesencephalon; RNase protection assay; Striatum

Indexed keywords

AMPHETAMINE DERIVATIVE; CALMODULIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG SENSITIZATION; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; MEASUREMENT; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; CALMODULIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; MESENCEPHALON; NEURAL PATHWAYS; PRESYNAPTIC TERMINALS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0034036846     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00142-1     Document Type: Article

References (51)

1. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci. 18:1998;10,579-10,593.
2. Bai G., Weiss B. The increase of calmodulin in PC12 cells induced by NGF is caused by differential expression of multiple mRNAs for calmodulin. J. cell. Physiol. 149:1991;414-421.
3. Berry F.B., Brown I.R. CaM I mRNA is localized to apical dendrites during postnatal development of neurons in the rat brain. J. Neurosci. Res. 43:1996;565-575.
4. Burchett S.A., Bannon M.J., Granneman J.G. RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J. Neurochem. 72:1999;1529-1533.
5. Burchett S.A., Volk M.L., Bannon M.J., Granneman J.G. Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. J. Neurochem. 70:1998;2216-2219.
6. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
7. Gardoni F., Caputi A., Cimino M., Pastorino L., Cattabeni F., Di Luca M. Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J. Neurochem. 71:1998;1733-1741.
8. Gnegy M.E. Calmodulin in neurotransmitter and hormone action. A. Rev. Pharmac. Toxic. 33:1993;45-70.
9. Gnegy M.E., Hewlett G.H., Pimputkar G. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment. Brain Res. 734:1996;35-42.
10. Gnegy M.E., Hewlett G.H., Yee S.L., Welsh M.J. Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562:1991;6-12.
11. Hayashi Y., Ishida A., Katagiri H., et al. Calcium- and calmodulin-dependent phosphorylation of AMPA type glutamate receptor subunits by endogenous protein kinases in the post-synaptic density. Brain Res. molec. Brain Res. 46:1997;338-342.
12. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience. 65:1995;1041-1050.
13. 2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J. Neurosci. 19:1999;3801-3808.
14. Koller M., Strehler E.E. Functional analysis of the promoters of the human CaMIII calmodulin gene and of the intronless gene coding for a calmodulin-like protein. Biochim. biophys. Acta. 1163:1993;1-9.
15. Koob G.F., Nestler E.J. The neurobiology of drug addiction [Review]. J. Neuropsychiat. clin. Neurosci. 9:1997;482-497.
16. Lu W., Chen H., Xue C.J., Wolf M.E. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse. 26:1997;269-280.
17. Lu W., Wolf M.E. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Brain Res. molec. Brain Res. 49:1997;137-148.
18. Lu W., Wolf M.E. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse. 32:1999;119-131.
19. MacManus J.P., Gillen M.F., Korczak B., Nojima H. Differential calmodulin gene expression in fetal, adult, and neoplastic tissues of rodents. Biochem. biophys. Res. Commun. 159:1989;278-282.
20. Michelhaugh S.K., Pimputkar G., Gnegy M.E. Alterations in calmodulin mRNA expression and calmodulin content in rat brain after repeated, intermittent amphetamine. Brain Res. molec. Brain Res. 62:1998;35-42.
21. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. natn. Acad. Sci. U.S.A. 89:1992;4270-4274.
22. Ni B., Brown I.R. Modulation of a neuronal calmodulin mRNA species in the rat brain stem by reserpine. Neurochem. Res. 18:1993;185-192.
23. Nojima H. Structural organization of multiple rat calmodulin genes. J. molec. Biol. 208:1989;269-282.
24. Nojima H., Sokabe H. Structure of a gene for rat calmodulin. J. molec. Biol. 193:1987;439-445.
25. Nojima H., Sokabe H. Structural organization of calmodulin genes in the rat genome. Adv. exp. Med. Biol. 255:1989;223-232.
26. Ostrander M.M., Hartman J., Badiani A., Robinson T.E., Gnegy M.E. The effect of environment on the changes in calmodulin in rat brain produced by repeated amphetamine treatment. Brain Res. 797:1998;339-341.
27. Pennartz C.M., Groenewegen H.J., Lopes d.S.F. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data [Review]. Prog. Neurobiol. 42:1994;719-761.
28. Persico A.M., Schindler C.W., O'Hara B.F., Brannock M.T., Uhl G.R. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Brain Res. molec. Brain Res. 20:1993;91-100.
29. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
30. Pierce R.C., Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17:1997;3254-3261.
31. Popov N., Schulzeck S., Nuss D., et al. Alterations in calmodulin content of rat brain areas after chronic application of haloperidol and amphetamine. Biomed. biochim. Acta. 47:1988;435-441.
32. Roberts-Lewis J.M., Welsh M.J., Gnegy M.E. Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Res. 384:1986;383-386.
33. Robinson T.E. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology. 84:1984;466-475.
34. Robinson T. E. (1991) The neurobiology of amphetamine psychosis: evidence from studies with an animal model. In Taniguchi Symposia on Brain Sciences, Biological Basis of Schizophrenic Disorders (ed. Nakazawa T.). Japan Scientific Societies Press, Tokyo.
35. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis [Review]. Brain Res. 396:1986;157-198.
36. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
37. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604.
38. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. biol. Chem. 272:1997;21,137-21,141.
39. Roseboom P.H., Hewlett G.H., Gnegy M.E. Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum. J. Pharmac. exp. Ther. 255:1990;197-203.
40. Segal D. S. and Kuczenski R. (1994) Behavioral pharmacology of amphetamine. In Amphetamine and its Analogs (eds Cho A. K. and Segal D. S.). Academic, San Diego.
41. SenGupta B., Friedberg F., Detera-Wadleigh S.D. Molecular analysis of human and rat calmodulin complementary DNA clones. Evidence for additional active genes in these species. J. biol. Chem. 262:1987;16,663-16,670.
42. Shimizu Y., Akiyama K., Kodama M., Ishihara T., Hamamura T., Kuroda S. Alterations of calmodulin and its mRNA in rat brain after acute and chronic administration of methamphetamine. Brain Res. 765:1997;247-258.
43. Simpson J.N., Wang J.Q., McGinty J.F. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum. Neuroscience. 69:1995;441-457.
44. Sola C., Tusell J.M., Serratosa J. Differential response of calmodulin genes in the mouse brain after systemic kainate administration. Neuroscience. 78:1997;155-164.
45. Solomon S.S., Palazzolo M.R., Takahashi T., Raghow R. Transcription factor Sp1 is necessary for basal calmodulin gene transcription and for its selective stimulation by insulin. Endocrinology. 138:1997;5052-5054.
46. Tiedge H., Bloom F.E., Richter D. RNA, whither goest thou? Science. 283:1999;186-187.
47. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
48. White F.J., Hu X.T., Zhang X.F., Wolf M.E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmac. exp. Ther. 273:1995;445-454.
49. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmac. exp. Ther. 264:1993;249-255.
50. Zhang S., Ehlers M.D., Bernhardt J.P., Su C.T., Huganir R.L. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron. 21:1998;443-453.
51. Zhang S.P., Natsukari N., Bai G., Nichols R.A., Weiss B. Localization of the multiple calmodulin messenger RNAs in differentiated PC12 cells. Neuroscience. 55:1993;571-582.